Reuters logo
BRIEF-Molecular Partners: update on clinical study of its oncology asset
October 12, 2017 / 5:10 AM / 2 months ago

BRIEF-Molecular Partners: update on clinical study of its oncology asset

Oct 12 (Reuters) - MOLECULAR PARTNERS AG:

* ‍FIRST PATIENT DOSED IN PHASE 1 CLINICAL STUDY OF MOLECULAR PARTNERS’ SECOND PROPRIETARY ONCOLOGY ASSET MP0274​

* ‍INITIAL SAFETY DATA ARE EXPECTED IN FIRST HALF OF 2018 AND INITIAL EFFICACY DATA TOWARDS END OF 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below